PT1027891E - Antagonista de neuropeptido y - Google Patents

Antagonista de neuropeptido y

Info

Publication number: PT1027891E
Authority: PT; Portugal
Prior art keywords: neuropeptido; antagonista; disorders; neuropeptide; antagonist
Prior art date: 1999-01-27

Application number

PT99310483T

Other languages

English (en)

Inventor

Marlys Hammond

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-27

Filing date

1999-12-23

Publication date

2005-04-29

1999-12-23 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-04-29 Publication of PT1027891E publication Critical patent/PT1027891E/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

PT99310483T 1999-01-27 1999-12-23 Antagonista de neuropeptido y PT1027891E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11739599P	1999-01-27	1999-01-27

Publications (1)

Publication Number	Publication Date
PT1027891E true PT1027891E (pt)	2005-04-29

Family

ID=22372692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99310483T PT1027891E (pt)	1999-01-27	1999-12-23	Antagonista de neuropeptido y

Country Status (17)

Country	Link
US (1)	US6197822B1 (pt)
EP (1)	EP1027891B1 (pt)
JP (1)	JP3502586B2 (pt)
KR (1)	KR100372989B1 (pt)
AT (1)	ATE285759T1 (pt)
AU (1)	AU1352000A (pt)
CA (1)	CA2296970C (pt)
CO (1)	CO5170482A1 (pt)
DE (1)	DE69922918T2 (pt)
DK (1)	DK1027891T3 (pt)
ES (1)	ES2234218T3 (pt)
HU (1)	HUP0000307A2 (pt)
IL (1)	IL134157A0 (pt)
NZ (1)	NZ502518A (pt)
PE (1)	PE20001416A1 (pt)
PT (1)	PT1027891E (pt)
ZA (1)	ZA200000313B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6407120B1 (en) *	1999-02-18	2002-06-18	Pfizer Inc.	Neuropeptide Y antagonists
US8377906B2 (en)	2004-06-04	2013-02-19	Ethicon, Inc.	Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US8129359B2 (en)	2004-06-04	2012-03-06	Ethicon, Inc.	Composition and method for treating post-surgical pain
US20070141156A1 (en) *	2005-12-21	2007-06-21	Uri Herzberg	Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
CN101578321B (zh)	2007-01-04	2012-02-15	Sk化学株式会社	具有极好发光度的聚亚芳基硫醚树脂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562862B1 (en) *	1994-10-20	2003-05-13	Eli Lilly And Company	Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
KR970707101A (ko) *	1994-11-07	1997-12-01	스피겔 알렌 제이	치환된 벤질아민 유도체; 신규한 부류의 신경펩타이드 y1 특이적 리간드(certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands)
EP0759441A3 (en) *	1995-06-30	1999-06-30	Eli Lilly And Company	Methods of treating neuropeptide Y-associated conditions
US6048900A (en) *	1998-02-13	2000-04-11	Bayer Corporation	Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
EP1033366A3 (en) *	1999-02-18	2000-12-27	Pfizer Products Inc.	Amide derivatives useful as Neuropeptide Y (NPY) antagonists

1999
- 1999-12-23 DE DE69922918T patent/DE69922918T2/de not_active Expired - Fee Related
- 1999-12-23 EP EP99310483A patent/EP1027891B1/en not_active Expired - Lifetime
- 1999-12-23 ES ES99310483T patent/ES2234218T3/es not_active Expired - Lifetime
- 1999-12-23 AT AT99310483T patent/ATE285759T1/de not_active IP Right Cessation
- 1999-12-23 PT PT99310483T patent/PT1027891E/pt unknown
- 1999-12-23 DK DK99310483T patent/DK1027891T3/da active
- 1999-12-29 CO CO99081405A patent/CO5170482A1/es not_active Application Discontinuation
2000
- 2000-01-20 IL IL13415700A patent/IL134157A0/xx unknown
- 2000-01-24 AU AU13520/00A patent/AU1352000A/en not_active Abandoned
- 2000-01-25 US US09/491,293 patent/US6197822B1/en not_active Expired - Fee Related
- 2000-01-25 CA CA002296970A patent/CA2296970C/en not_active Expired - Fee Related
- 2000-01-25 ZA ZA200000313A patent/ZA200000313B/xx unknown
- 2000-01-26 NZ NZ502518A patent/NZ502518A/en unknown
- 2000-01-26 KR KR10-2000-0003550A patent/KR100372989B1/ko not_active IP Right Cessation
- 2000-01-26 HU HU0000307A patent/HUP0000307A2/hu unknown
- 2000-01-26 PE PE2000000055A patent/PE20001416A1/es not_active Application Discontinuation
- 2000-01-27 JP JP2000018938A patent/JP3502586B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2000212077A (ja)	2000-08-02
IL134157A0 (en)	2001-04-30
DE69922918T2 (de)	2006-03-30
ES2234218T3 (es)	2005-06-16
US6197822B1 (en)	2001-03-06
JP3502586B2 (ja)	2004-03-02
ATE285759T1 (de)	2005-01-15
KR20000053607A (ko)	2000-08-25
DK1027891T3 (da)	2005-05-09
NZ502518A (en)	2001-06-29
CO5170482A1 (es)	2002-06-27
ZA200000313B (en)	2001-07-25
DE69922918D1 (de)	2005-02-03
HU0000307D0 (en)	2000-03-28
HUP0000307A2 (hu)	2000-12-28
CA2296970C (en)	2004-11-02
PE20001416A1 (es)	2000-12-18
EP1027891B1 (en)	2004-12-29
EP1027891A3 (en)	2002-07-17
CA2296970A1 (en)	2000-07-27
KR100372989B1 (ko)	2003-02-25
AU1352000A (en)	2000-08-03
EP1027891A2 (en)	2000-08-16

Publication	Publication Date	Title
DE69925133D1 (de)	2005-06-09	Pyrrolobenzodiazepine
ATE364198T1 (de)	2007-06-15	1,3-dihydro-1-oxo-2h-indenderivat
ATE512594T1 (de)	2011-07-15	Verbesserung des zustandes älterer haustiere
ID28483A (id)	2001-05-31	2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
ITMI20021729A1 (it)	2004-02-02	Apparecchio emanatore per l'emanazione di soluzioni.
DE60025958D1 (de)	2006-04-20	14,15-beta-methylen substituierte androgene
ATE277912T1 (de)	2004-10-15	Pyrimidine-2,4,6-trione als matrixmetalloproteinase-hemmer
PT1027891E (pt)	2005-04-29	Antagonista de neuropeptido y
SI1197223T1 (pt)	2005-08-31
CY1111900T1 (el)	2015-11-04	Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda)
PT896822E (pt)	2003-07-31	4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y
BR0000486A (pt)	2001-08-21	Antagonistas do neuropeptìdeo y
ITMI20001848A0 (it)	2000-08-08	Faramaci per l'incontinenza.
TR200003084T2 (tr)	2001-02-21	Paroxetine askorbat
ES1042371Y (es)	2000-01-16	"elevador perfeccionado".
ES1042364Y (es)	2000-01-16	"pañal perfeccionado".
ES1042703Y (es)	2000-02-16	"cuadro perfeccionado".
ES1042496Y (es)	2000-02-01	"pilona sumible".
IT1320767B1 (it)	2003-12-10	Composti ad attivita' anti-hsv.
ES1051471Y (es)	2002-12-01	Sandalia multiforme perfeccionada
UA3340S (uk)	1999-12-29	Машина "смита"
IT248736Y1 (it)	2003-02-12	Dispositivo perfezionato per l'ossigeno-ozono terapia.
ATE338046T1 (de)	2006-09-15	2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität
SE9903774D0 (sv)	1999-10-20	Hålslag kongerens
ITMC20020043A1 (it)	2003-11-24	"macchina per la bricchettatura".